Education
About Us
Working with TipRanks
Follow Us
Shandong Weigao Group Medical Polymer Co Class H (DE:UK2)
:UK2
RESEARCH TOOLSreports
Total Valuation
Shandong Weigao Group Medical Polymer Co has a market cap or net worth of €2.89B. The enterprise value is €14.26B.
Market Cap€2.89B
Enterprise Value€14.26B
Share Statistics
Shandong Weigao Group Medical Polymer Co has 4,522,332,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,522,332,000
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Shandong Weigao Group Medical Polymer Co’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.04M
Profits Per Employee186.27K
Employee Count12,719
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Shandong Weigao Group Medical Polymer Co is ―. Shandong Weigao Group Medical Polymer Co’s PEG ratio is ―.
PE Ratio―
PS Ratio3.90
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Shandong Weigao Group Medical Polymer Co had revenue of 13.23B and earned 2.00B in profits. Earnings per share was 0.44.
Revenue13.23B
Gross Profit6.64B
Operating Income2.18B
Pretax Income2.37B
Net Income2.00B
EBITDA3.55B
Earnings Per Share (EPS)0.44
Cash Flow
In the last 12 months, operating cash flow was 2.80B and capital expenditures -647.58M, giving a free cash flow of 2.15B billion.
Operating Cash Flow2.80B
Free Cash Flow2.15B
Free Cash Flow per Share0.48
Dividends & Yields
Shandong Weigao Group Medical Polymer Co pays an annual dividend of €0.015, resulting in a dividend yield of 3.61%
Dividend Per Share€0.015
Dividend Yield3.61%
Payout Ratio20.83%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.26
52-Week Price Change7.27%
50-Day Moving Average0.61
200-Day Moving Average0.55
Relative Strength Index (RSI)46.10
Average Volume (3m)0.00
Important Dates
Shandong Weigao Group Medical Polymer Co upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJun 02, 2025
Financial Position
Shandong Weigao Group Medical Polymer Co as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Shandong Weigao Group Medical Polymer Co has paid 307.58M in taxes.
Income Tax307.58M
Effective Tax Rate―
Enterprise Valuation
Shandong Weigao Group Medical Polymer Co EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Shandong Weigao Group Medical Polymer Co has €7.33B in cash and marketable securities with ¥5.34B in debt, giving a net cash position of -€3.16B billion.
Cash & Marketable Securities€7.33B
Total Debt¥5.34B
Net Cash-€3.16B
Net Cash Per Share-€0.70
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Shandong Weigao Group Medical Polymer Co is €0.59, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€0.59
Price Target Upside-4.98% Downside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―